Comparison of Trunk Excursion Measured by Microsoft Kinect 2 and Force Plate
PM&R · 2026-11 · 18 (S3)
DOI: 10.1002/pmrj.13_70259 ↗Kurz gefasst
Fachartikel in der Zeitschrift PM&R, online erschienen am 10.11.2026. Verfasst von Justin Chiu und 1 weiteren Autor:innen.
Abstract (Originalsprache)
products for approved medical conditions.Pennsylvania (PA) and New Jersey (NJ) both have their own state-run medical marijuana programs that allow patients to obtain cannabis products after physician certification.This study evaluates the differences in medical marijuana usage in New Jersey and Pennsylvania from 2019 to 2021, prior to the recreational legalization in New Jersey.
Design
Retrospective ecological study Setting: New Jersey and Pennsylvania Participants: Aggregated data on medical marijuana users in New Jersey and Pennsylvania Interventions: New Jersey Cannabis Regulatory Commission and Pennsylvania Medical Marijuana Program annual reports were used to obtain the number of patients using medical marijuana per qualifying condition.Prevalence rates of qualifying conditions and Census data from 2020 were used to estimate the number of patients in NJ and PA living with each qualifying condition.These values were used to determine the average rate of medical marijuana use per condition in each state from 2019 to 2021.Usage rates from each state were compared using chisquare analyses, and percent differences were calculated.Main Outcome Measures: Average medical marijuana usage rates from 2019-2021 and percent differences between each state.
Results
For all qualifying conditions, there was a statistically significant difference in the usage rates of medical marijuana when comparing NJ to PA from 2019 to 2021 with p-values ranging from < 0.001 to 0.041.Marijuana usage rates were 26% to 340% higher in PA, with the exception of use for spasticity, which was 67% higher in NJ.
Conclusions
Differences in medical marijuana usage among neighboring states suggest that utilization is not solely driven by disease prevalence.Policy, access, and provider education and practices may be contributing factors, highlighting the need for individual-level research.Such research could inform standardized, evidencebased guidelines for prescribing medical marijuana, promoting more equitable and appropriate use across states.
Zitieren
APA
Chiu, J., & Hatch, M. N. (2026). Comparison of Trunk Excursion Measured by Microsoft Kinect 2 and Force Plate. PM&R, 18(S3). https://doi.org/10.1002/pmrj.13_70259
Vancouver
Chiu J, Hatch MN. Comparison of Trunk Excursion Measured by Microsoft Kinect 2 and Force Plate. PM&R. 2026;18(S3). doi:10.1002/pmrj.13_70259
BibTeX
@article{Chiu2026,
author = {Chiu, Justin and Hatch, Maya N.},
title = {Comparison of Trunk Excursion Measured by Microsoft Kinect 2 and Force Plate},
journal = {PM&R},
year = {2026},
volume = {18},
number = {S3},
doi = {10.1002/pmrj.13_70259}
}
EUVIMED